Laurus Labs Ltd 2023 AR2

The report highlights Laurus Labs Limited's performance for the fiscal year 2022-23, showcasing a 22% revenue growth to reach ₹6,041 crores, driven by a 136% growth in its CDMO-Synthesis business. The company continued its expansion with capital expenditures reaching ₹990 crores, representing 16% of revenues. Key achievements include the establishment of a GMP CAR-T cell therapy facility in Navi-Mumbai through its investment in ImmunoACT and the filing of its first NDA for a pediatric HIV product using a novel oral dissolving film platform. On the environmental front, the company acquired a 26% stake in Ethan Energy to boost captive renewable power and completed its first physical climate risk assessment.

Company: Laurus Labs Ltd

Sector: Health Care

Country: India

Year: 2023

Type: AR2

Pages: 288

Back to company

Laurus Labs Ltd

Laurus Labs Ltd 2023 Annual Report

Annual Report

The report highlights Laurus Labs Limited's performance for the fiscal year 2022-23, showcasing a 22% revenue growth to reach ₹6,041 crores, driven by a 136% growth in its CDMO-Synthesis business. The company continued its expansion with capital expenditures reaching ₹990 crores, representing 16% of revenues. Key achievements include the establishment of a GMP CAR-T cell therapy facility in Navi-Mumbai through its investment in ImmunoACT and the filing of its first NDA for a pediatric HIV product using a novel oral dissolving film platform. On the environmental front, the company acquired a 26% stake in Ethan Energy to boost captive renewable power and completed its first physical climate risk assessment.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2023

Reporting Period

Apr 1, 2022 - Mar 31, 2023

Fiscal Year

2023

Type

Annual Report with Sustainability Disclosures

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Scope 3:

Energy Consumption

Renewable Energy

Water Consumption

Total Waste

Women on Board

Women in Management

Workplace Fatalities

Employees